.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
MAGMAS inhibition in Glioblastoma offers a new hope for overcoming the metabolic hurdles of recurrent brain tumors. Glioblastoma (GBM) remains the most aggressive primary brain malignancy, with a nearly universal recurrence rate. Most patients face relapse within nine months of diagnosis because current treatments fail to eliminate resistant cells. Scientists are now investigating the mitochondria-associated protein MAGMAS as a strategic target to re-sensitize these tumors to chemotherapy.
MAGMAS, also known as PAM16, is a nuclear-encoded mitochondrial protein and a vital subunit of the TIM23 complex. This complex regulates the trafficking of essential proteins into the mitochondrial matrix. Recent studies show that MAGMAS levels are significantly higher in recurrent GBM and chemoresistant glioma cells. Consequently, this protein helps tumor cells maintain energy production and survive metabolic stress during chemotherapy. Additionally, researchers found a positive correlation between MAGMAS expression and MGMT, the enzyme responsible for repairing DNA damage caused by temozolomide (TMZ).
To target this pathway, researchers utilized BT9, a small molecule inhibitor that specifically binds to MAGMAS. This MAGMAS inhibition in Glioblastoma reduces mitochondrial respiration and impairs oxidative phosphorylation. Furthermore, combining BT9 with TMZ significantly increased cell death across various glioma lines. This synergy remained effective even in cells typically resistant to standard chemotherapy. In animal studies, silencing the PAM16 gene through shRNA significantly improved the survival rates of intracranial xenograft models. Therefore, targeting mitochondrial protein trafficking presents a viable therapeutic strategy for high-grade astrocytomas.
MAGMAS facilitates the transport of proteins into the mitochondria, which supports the tumor's metabolic flexibility. Its overexpression helps glioma cells survive the oxidative stress and DNA damage induced by temozolomide.
BT9 is a small molecule inhibitor that targets MAGMAS. It impairs mitochondrial respiration and induces apoptosis, effectively sensitizing chemoresistant cells to the effects of temozolomide.
Preclinical studies indicate that MAGMAS inhibitors like BT9 can effectively reach the brain, making them suitable candidates for treating intracranial malignancies like glioblastoma.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.
References
Lepe JJ et al. MAGMAS Inhibition Enhances Temozolomide Efficacy in Chemotherapy-Resistant Glioblastoma Models. Cancer Res Commun. 2026 May 06. doi: 10.1158/2767-9764.CRC-25-0493. PMID: 42090721.
Di K et al. Magmas inhibition as a potential treatment strategy in malignant glioma. PMC. 2018 Nov 09. doi: 10.1007/s11060-018-03023-z.
Lomeli N et al. Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma. PMC. 2022. doi: 10.1038/s41598-022-12345-6.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Research shows MAGMAS inhibition sensitizes resistant glioblastoma to temozolomide by disrupting mitochondrial protein trafficking and cellular respiration....
2 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
